Senators Bring Back Bill Mandating Medicare Payment For Breakthrough Technologies

Four US senators are leading a bipartisan effort to bring potentially life-saving medical treatments to Medicare beneficiaries by requiring reimbursement for breakthrough technologies cleared by the FDA. 

AI ROBOT.
• Source: Alamy

Senators Richard Burr, R-NC, Michael Bennet, D-CO, Tom Carper, D-DE, and Tim Scott, R-SC, have reintroduced the “New Opportunities for Value to Extend Lives (NOVEL) Act,” legislation first introduced in 2019 that never made it through committee.

The NOVEL Act, according to a Republican Senate aide on the Health, Education, Labor and Pensions (HELP) Committee, has...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

FDA Publishes Final Cybersecurity Guidance To Replace Final Cybersecurity Guidance

 

The US FDA has issued an updated final guidance document on cybersecurity considerations for medical device manufacturers that replaces a previous final guidance the agency issued in 2023.

New Regulation Significantly Expands eIFU Usage Scope

 

Amendment brings new benefits for device accessories and aesthetic devices used by healthcare professionals.

New EU Rules Limit Chinese Participation In Medtech Procurement

 

From June 30, new European Commission rules will attempt to redress an imbalance in medtech trade between the EU and the People’s Republic of China.

FDA Regulations ‘Lock Out’ Clinically Proven Neuromodulation Devices

 

Flow Neuroscience's neuromodulation headset for the treatment of depression is approved and marketed in the EU. However, two years on, the company is still waiting for US FDA approval despite being assigned breakthrough device designation.

More from Policy & Regulation